Core Laboratories Inc reports results for the quarter ended in March - Earnings Summary

Core Laboratories

25/04/2024 24:08

* Core Laboratories Inc  CLB.N  reported quarterly adjusted
earnings of 19 cents​​ per share for the quarter ended in March,
identical to the same quarter last year.  The mean expectation
of eight analysts for the quarter was for earnings of 16 cents
per share. Wall Street expected results to range from 15 cents
to 17 cents per share.
    * Revenue rose 1% to $129.64 million from a year ago;
analysts
expected $124.44 million. 
    * Core Laboratories Inc's reported EPS for the quarter was 7
cents​.
    * Core Laboratories Inc shares had fallen by 0.5% this
quarter and
lost 3.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 22.1%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 6
"hold" and 2 "sell" or "strong sell." 
    * The average consensus recommendation for the business
support
services peer group is also "hold"

Wall Street's median 12-month price target for Core Laboratories
Inc is $17.50 
This summary was machine generated from LSEG data April 24 at
11:08 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      0.16           0.19           Beat
 Dec. 31 2023      0.19           0.19           Met
 Sep. 30 2023      0.22           0.22           Met
 Jun. 30 2023      0.20           0.21           Beat